Ann: Imugene Presents New PD1-Vaxx Data at the 2022 WCLC, page-7

  1. 173 Posts.
    lightbulb Created with Sketch. 78
    “It’s particularly gratifying to have followed a patient in the trial for over 18 months where their tumour burden has been reduced to zero. For such a late-stage patient, having a chemo-free alternative could mean a very real difference to their quality of life, she added”.

    WOWeeeee !!!!
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
36.0¢
Change
-0.010(2.70%)
Mkt cap ! $81.29M
Open High Low Value Volume
37.0¢ 37.0¢ 36.0¢ $75.14K 206.2K

Buyers (Bids)

No. Vol. Price($)
4 83735 36.0¢
 

Sellers (Offers)

Price($) Vol. No.
36.5¢ 4731 5
View Market Depth
Last trade - 10.20am 18/07/2025 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.